Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium
16/03/2026 11:33
March 16 (Reuters) - Crescita Therapeutics Inc CTX.TO: CRESCITA ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY CLINACTIV HOLDINGS IN AN ALL-CASH TRANSACTION AT A SIGNIFICANT PREMIUM CRESCITA THERAPEUTICS INC - DEAL VALUED AT $0.80 PER SHARE, MINIMUM $0.75 PER SHARE Source text: ID:nBw1t79qza Further company coverage: CTX.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium